Specialty pharmaceutical company focused on the development of therapeutics to treat front of the eye diseases

Sectors
Healthcare
Life Sciences
First Invested
2007
Early
Company Status
Acquired
Acquired by Nicox S.A.
Associated Team
Ali Behbahani, MD